FDA Inspection 1021116 — Kaiser Permanente Center For Reproductive Health
The FDA completed an inspection of Kaiser Permanente Center For Reproductive Health on July 11, 2017 in Sacramento, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 11, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Sacramento, CA (United States)